natgillin/translations-raw huggingface dataset:
EU/ 1/ 02/ 231/ 001
Velikost pakiranja
Mixtard 30
EU/ 1/ 02/ 231/ 001 Mixtard 30
Subcutaneous use Vial (glass)
za subkutano uporabo
10ml (1.4 mg/ ml)
viala (steklo)
EU/ 1/ 02/ 231/ 002
EU/ 1/ 02/ 231/ 002 Mixtard 30
EU/ 1/ 02/ 231/ 003
EU/ 1/ 02/ 231/ 003 Mixtard 30
EU/ 1/ 02/ 231/ 004
EU/ 1/ 02/ 231/ 004 Mixtard 30
EU/ 1/ 02/ 231/ 005
EU/ 1/ 02/ 231/ 005 Mixtard 10 Penfill
EU/ 1/ 02/ 231/ 006
EU/ 1/ 02/ 231/ 006 Mixtard 10 Penfill
EU/ 1/ 02/ 231/ 007
EU/ 1/ 02/ 231/ 007 Mixtard 10 Penfill
EU/ 1/ 02/ 231/ 008
EU/ 1/ 02/ 231/ 008 Mixtard 20 Penfill
EU/ 1/ 02/ 231/ 009
EU/ 1/ 02/ 231/ 009 Mixtard 20 Penfill
EU/ 1/ 02/ 231/ 010
EU/ 1/ 02/ 231/ 010 Mixtard 20 Penfill
EU/ 1/ 02/ 231/ 011
EU/ 1/ 02/ 231/ 011 Mixtard 30 Penfill
EU/ 1/ 02/ 231/ 012
EU/ 1/ 02/ 231/ 012 Mixtard 30 Penfill
EU/ 1/ 02/ 231/ 013
EU/ 1/ 02/ 231/ 013 Mixtard 30 Penfill
EU/ 1/ 02/ 231/ 014
EU/ 1/ 02/ 231/ 014 Mixtard 40 Penfill
EU/ 1/ 02/ 231/ 015
EU/ 1/ 02/ 231/ 015 Mixtard 40 Penfill
EU/ 1/ 02/ 231/ 016
EU/ 1/ 02/ 231/ 016 Mixtard 40 Penfill
EU/ 1/ 02/ 231/ 017
1/ 3 EU številka
Mixtard 50 Penfill
EU/ 1/ 02/ 231/ 017 Mixtard 50 Penfill
EU/ 1/ 02/ 231/ 018
EU/ 1/ 02/ 231/ 018 Mixtard 50 Penfill
Mixtard 50 Penfill
100 i. e.
100 IU/ ml
suspenzija za injiciranje
Suspension for injection
za subkutano uporabo
Subcutaneous use Cartridge (glass)
injekcijski vložek (steklo)
EU/ 1/ 02/ 231/ 019
EU/ 1/ 02/ 231/ 019 Mixtard 50 Penfill
EU/ 1/ 02/ 231/ 020
EU/ 1/ 02/ 231/ 020 Mixtard 10 NovoLet 100 i. e.
Mixtard 10 NovoLet 100 IU/ ml
suspenzija za injiciranje
EU/ 1/ 02/ 231/ 021
EU/ 1/ 02/ 231/ 021 Mixtard 10 NovoLet 100 i. e.
EU/ 1/ 02/ 231/ 022
EU/ 1/ 02/ 231/ 022 Mixtard 20 NovoLet 100 i. e.
Mixtard 20 NovoLet 100 IU/ ml
suspenzija za injiciranje
EU/ 1/ 02/ 231/ 023
EU/ 1/ 02/ 231/ 023 Mixtard 20 NovoLet 100 i. e.
EU/ 1/ 02/ 231/ 024
EU/ 1/ 02/ 231/ 024 Mixtard 30 NovoLet 100 i. e.
Mixtard 30 NovoLet 100 IU/ ml
suspenzija za injiciranje
EU/ 1/ 02/ 231/ 025
EU/ 1/ 02/ 231/ 025 Mixtard 30 NovoLet 100 i. e.
EU/ 1/ 02/ 231/ 026
EU/ 1/ 02/ 231/ 026 Mixtard 40 NovoLet 100 i. e.
Mixtard 40 NovoLet 100 IU/ ml
suspenzija za injiciranje
EU/ 1/ 02/ 231/ 027
EU/ 1/ 02/ 231/ 027 Mixtard 40 NovoLet 100 i. e.
EU/ 1/ 02/ 231/ 028
EU/ 1/ 02/ 231/ 028 Mixtard 50 NovoLet 100 i. e.
Mixtard 50 NovoLet 100 IU/ ml
suspenzija za injiciranje
EU/ 1/ 02/ 231/ 029
EU/ 1/ 02/ 231/ 029 Mixtard 50 NovoLet 100 i. e.
EU/ 1/ 02/ 231/ 030
EU/ 1/ 02/ 231/ 030 Mixtard 30 InnoLet 100 i. e.
Mixtard 30 InnoLet 100 IU/ ml
suspenzija za injiciranje
EU/ 1/ 02/ 231/ 031
EU/ 1/ 02/ 231/ 031 Mixtard 30 InnoLet 100 i. e.
EU/ 1/ 02/ 231/ 032
EU/ 1/ 02/ 231/ 032 Mixtard 30 InnoLet 100 i. e.
EU/ 1/ 02/ 231/ 037
EU/ 1/ 02/ 231/ 037 Mixtard 30
Mixtard 30 40 IU/ ml suspension for injection in a vial.
Mixtard 30 40 i. e. / ml suspenzija za injiciranje v viali
Mixtard is a mixture of dissolved insulin and isophane (NPH) insulin.
Mixtard je mešanica raztopljenega insulina in insulina izofan (NPH).
Mixtard 30 consists of 30% dissolved insulin and 70% isophane insulin.
Mixtard 30 vsebuje 30% raztopljenega insulina in 70% insulina izofan.
Mixtard is a dual-acting insulin.
Mixtard je insulin z dvojnim delovanjem.
It is biphasic formulation containing both fast-acting and long-acting insulin.
Je dvofazen pripravek, ki vsebuje hitrodelujoči in dolgodelujoči insulin.
Mixtard is administered subcutaneously in the thigh or abdominal wall.
Mixtard ponavadi injiciramo subkutano v stegno ali trebušno steno.
Mixtard is accompanied by a package leaflet with detailed instruction for use to be followed.
Insulinu Mixtard je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
If an adjustment is needed when switching the patients to Mixtard, it may occur with the first dose or during the first several weeks or months.
Če je po prehodu bolnikov na Mixtard potrebna prilagoditev, je to lahko potrebno že pri prvem odmerku ali v prvih nekaj tednih ali mesecih.
On rare occasions, injection site reactions may require discontinuation of Mixtard.
V redkih primerih utegne biti zaradi reakcij na mestu injiciranja potrebna prekinitev uporabe insulina Mixtard.
Mixtard contains metacresol, which may cause allergic reactions.
Mixtard vsebuje metakrezol, ki lahko povzroči alergijske reakcije.
However, the Mixtard dosage may need to be adjusted.
Lahko pa je potrebna prilagoditev odmerjanja zdravila Mixtard.
Frequencies of adverse drug reactions from clinical trials that are considered related to Mixtard are listed below.
Spodaj so navedene pogostnosti neželenih reakcij, ki so po splošni presoji povezane z zdravilom Mixtard.
However, hypoglycaemia may develop over sequential stages:
Zato je priporočljivo, da imajo diabetični bolniki pri sebi nekaj kock sladkorja, bonbone, piškote ali sadni sok, ki vsebuje sladkor.
It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice. • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
5 • Hude hipoglikemije, ko je bolnik nezavesten, je mogoče zdraviti z glukagonom (0, 5 do 1 mg), ki ga da intramuskularno ali subkutano ustrezno podučena oseba, ali z glukozo, ki jo da intravensko zdravstveni delavec.
After removing Mixtard vial from the refrigerator it is recommended to allow the vial to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem, ko vialo insulina Mixtard vzamete iz hladilnika, jo je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
7 Insulin suspensions should not be used if they do not appear uniformly white and cloudy after resuspension.
Suspenzij insulina se ne sme uporabiti, če po resuspendiranju niso enakomerno bele in motne.
Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark
7 Novo Allé DK- 2880 Bagsværd Danska
Mixtard 30 100 IU/ ml suspension for injection in a vial.
Mixtard 30 100 i. e. / ml suspenzija za injiciranje v viali
11 hypoglycaemia or have frequent episodes of hypoglycaemia.
11 odsotnim zaznavanjem opozorilnih znakov hipoglikemije in pri tistih, ki imajo pogoste hipoglikemije.
Isolated spontaneous cases are presented as very rare defined as < 1/ 10,000 including isolated reports.
Posamezni spontani primeri so opisani kot zelo redki in opredeljeni kot < 1/ 10. 000, vklučno s posameznimi primeri.
It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice. • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
12 • Hude hipoglikemije, ko je bolnik nezavesten, je mogoče zdraviti z glukagonom (0, 5 do 1 mg), ki ga da intramuskularno ali subkutano ustrezno podučena oseba, ali z glukozo, ki jo da intravensko zdravstveni delavec.
After removing Mixtard vial from the refrigerator it is recommended to allow the vial to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko vialo insulina Mixtard vzamete iz hladilnika, jo je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
14 Any unused product or waste material should be disposed of in accordance with local requirements.
Neuporabljeno zdravilo ali odpadni material zavrzite v skladu z lokalnimi predpisi.
Mixtard 10 Penfill 100 IU/ ml suspension for injection in a cartridge.
Mixtard 10 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku
Mixtard 10 consists of 10% dissolved insulin and 90% isophane insulin.
Mixtard 10 vsebuje 10% raztopljenega insulina in 90% insulina izofan.
20 5.3 Preclinical safety data
5. 3 Predklinični podatki o varnosti
6.6 Special precaustions for disposal and other handling
6. 6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom
Mixtard Penfill is for single person use only.
Mixtard Penfill je namenjen uporabi ene same osebe.
21 After removing Mixtard Penfill from the refrigerator it is recommended to allow the Penfill to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko Mixtard Penfill vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 20 Penfill 100 IU/ ml suspension for injection in a cartridge.
Mixtard 20 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku
Mixtard 20 consists of 20% dissolved insulin and 80% isophane insulin.
Mixtard 20 vsebuje 20% raztopljenega insulina in 80% insulina izofan.
28 After removing Mixtard Penfill from the refrigerator it is recommended to allow the Penfill to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko Mixtard Penfill vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 30 Penfill 100 IU/ ml suspension for injection in a cartridge.
Mixtard 30 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku
Mixtard is administered subcutaneously in the thigh or abdominal wall.
Mixtard se ponavadi injiciramo subkutano v stegno ali trebušno steno.
35 Insulin preparations which have been frozen must not be used.
Pripravkov insulina, ki so bili zamrznjeni, se ne sme uporabiti.
After removing Mixtard Penfill from the refrigerator it is recommended to allow the Penfill to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko Mixtard Penfill vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Any unused product or waste material should be disposed of in accordance with local requirements.
35 Neuporabljeno zdravilo ali odpadni material zavrzite v skladu z lokalnimi predpisi.
Mixtard 40 Penfill 100 IU/ ml suspension for injection in a cartridge.
Mixtard 40 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku
Mixtard 40 consists of 40% dissolved insulin and 60% isophane insulin.
Mixtard 40 vsebuje 40% raztopljenega insulina in 60% insulina izofan.
Mixtard 50 Penfill 100 IU/ ml suspension for injection in a cartridge.
Mixtard 50 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku
Mixtard 50 consists of 50% dissolved insulin and 50% isophane insulin.
Mixtard 50 vsebuje 50% raztopljenega insulina in 50% insulina izofan.
48 5.3 Preclinical safety data
5. 3 Predklinični podatki o varnosti
49 After removing Mixtard Penfill from the refrigerator it is recommended to allow the Penfill to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko Mixtard Penfill vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo (do 25 °C), preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 10 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen.
Mixtard 10 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Mixtard NovoLet is designed to be used with NovoFine needles.
Mixtard NovoLet je namenjen za uporabo z iglami NovoFine.
Frequencies of adverse drug reactions from clinical trials that are considered related to Mixtard are listed below.
Spodaj so navedene pogostnosti neželenih reakcij, ki so bile po splošni presoji povezane z zdravilom Mixtard.
However, hypoglycaemia may develop over sequential stages: • Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.
54 • Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
Mixtard NovoLet is for single person use only.
Mixtard NovoLet je namenjen uporabi ene same osebe.
After removing Mixtard NovoLet from the refrigerator it is recommended to allow the NovoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
56 Potem ko Mixtard NovoLet vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 20 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen.
Mixtard 20 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
61 4.9 Overdose
61 • Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
After removing Mixtard NovoLet from the refrigerator it is recommended to allow the NovoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko Mixtard NovoLet vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Insulin suspensions should not be used if they do not appear uniformly white and cloudy after resuspension.
63 Suspenzij insulina se ne sme uporabiti, če po resuspendiranju niso enakomerno bele in motne.
Mixtard 30 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen.
Mixtard 30 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
68 4.9 Overdose
68 • Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
70 Pens should only be used in combination with products that are compatible with them and allow the pens to function safely and effectively.
Injekcijske peresnike se sme uporabljati samo s sistemi, s katerimi so kompatibilni in ki omogočajo varno in učinkovito delovanje teh peresnikov.
After removing Mixtard NovoLet from the refrigerator it is recommended to allow the NovoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
70 Potem ko Mixtard NovoLet vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 40 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen.
Mixtard 40 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
75 4.9 Overdose
75 • Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
After removing Mixtard NovoLet from the refrigerator it is recommended to allow the NovoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
77 Potem ko Mixtard NovoLet vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 50 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen.
Mixtard 50 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
82 4.9 Overdose
82 • Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
84 Mixtard NovoLet is for single person use only.
Mixtard NovoLet je namenjen uporabi ene same osebe.
After removing Mixtard NovoLet from the refrigerator it is recommended to allow the NovoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
84 Potem ko Mixtard NovoLet vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 30 InnoLet 100 IU/ ml suspension for injection in a pre-filled pen.
Mixtard 30 InnoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Mixtard InnoLet is designed to be used with NovoFine short cap needles of 8 mm or shorter in length.
Mixtard InnoLet je namenjen za uporabo z iglami NovoFine s kratkim pokrovčkom, dolgimi 8 mm ali manj.
However, hypoglycaemia may develop over sequential stages: • Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.
89 • Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
Mixtard InnoLet is for single person use only.
Mixtard InnoLet je namenjen uporabi ene same osebe.
After removing Mixtard InnoLet from the refrigerator it is recommended to allow the InnoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko Mixtard InnoLet vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Insulin suspensions should not be used if they do not appear uniformly white and cloudy after resuspension.
91 Suspenzij insulina se ne sme uporabiti, če po resuspendiranju niso enakomerno bele in motne.
Mixtard 30 FlexPen 100 IU/ ml suspension for injection in a pre-filled pen.
Mixtard 30 FlexPen 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Mixtard FlexPen is designed to be used with NovoFine short cap needles of 8 mm or shorter in length.
Mixtard FlexPen je namenjen za uporabo z iglami NovoFine s kratkim pokrovčkom, dolgimi 8 mm ali manj.
Mixtard FlexPen is for single person use only.
98 Mixtard FlexPen je namenjen uporabi ene same osebe.
After removing Mixtard Flexpen from the refrigerator it is recommended to allow the FlexPen to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Potem ko Mixtard FlexPen vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Mixtard 30 Penfill and FlexPen:
Mixtard Penfill in FlexPen:
Mixtard 30 40 IU/ ml suspension for injection in a vial Insulin human (rDNA),
Mixtard 30 40 i. e. / ml suspenzija za injiciranje v viali humani insulin (rDNA)
Mixtard 30 vial 40 IU/ ml
Mixtard 30 viala 40 i. e. / ml
Mixtard 30 40 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 30 40 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 30 100 IU/ ml suspension for injection in a vial Insulin human (rDNA)
Mixtard 30 100 i. e. / ml suspenzija za injiciranje v viali humani insulin (rDNA)
Mixtard 30 vial 100 IU/ ml
Mixtard 30 viala 100 i. e. / ml
Mixtard 30 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 30, 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 30 40 IU/ ml suspension for injection in a vial Insulin human (rDNA)
Mixtard 30 40 i. e. / ml suspenzija za injiciranje v viali humani insulin (rDNA)
110 Store in a refrigerator (2°C - 8°C) Do not freeze Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C
Med uporabo:
Mixtard 10 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Mixtard 10 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Mixtard 10 Penfill is for use by one person only
Mixtard 10 Penfill je namenjen uporabi ene same osebe.
Mixtard 10 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 10 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 20 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Mixtard 20 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Mixtard 20 Penfill is for use by one person only
Mixtard 20 Penfill je namenjen uporabi ene same osebe.
Mixtard 20 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 20 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 30 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA),
Mixtard 30 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Mixtard 30 Penfill is for use by one person only
Mixtard 30 Penfill je namenjen uporabi ene same osebe.
Mixtard 30 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 30 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 40 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Mixtard 40 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Mixtard 40 Penfill is for use by one person only
Mixtard 40 Penfill je namenjen uporabi ene same osebe.
Mixtard 40 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 40 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 50 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Mixtard 50 Penfill 100 i. e. / ml suspenzija za injiciranje v injekcijskem vložku humani insulin (rDNA)
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Mixtard 50 Penfill is for use by one person only
Mixtard 50 Penfill je namenjen uporabi ene same osebe.
Mixtard 50 Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 50 Penfill 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 10 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Mixtard 10 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Mixtard 10 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Mixtard 10 NovoLet is for use by one person only
Mixtard 10 NovoLet je namenjen uporabi ene same osebe.
Mixtard 10 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 10 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 20 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Mixtard 20 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Mixtard 20 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Mixtard 20 NovoLet is for use by one person only
Mixtard 20 NovoLet je namenjen uporabi ene same osebe.
Mixtard 20 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 20 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 30 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Mixtard 30 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)
Subcutaneous use Mixtard 30 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Mixtard 30 NovoLet is for use by one person only
Mixtard 30 NovoLet je namenjen uporabi ene same osebe.
Mixtard 30 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
Mixtard 30 NovoLet 100 i. e. / ml suspenzija za injiciranje humani insulin (rDNA) Za subkutano uporabo.
Mixtard 40 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Mixtard 40 NovoLet 100 i. e. / ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin (rDNA)